The EU has unveiled plans for greater Health Technology Assessment harmonisation this week - and put the potential benefits for life sciences centre stage.
Andrew Powrie-Smith from EFPIA talks about the European pharmaceutical industry organisation's new #WeWontRest campaign, which highlights the sector's efforts to find better treatments and cure
Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials.
Leaders from associations representing the entire EU and UK pharmaceutical sector have written a joint letter to chief negotiators warning of the potential impact of an 'unorderly' Brexit o